Abstract
Sulfasalazine reduces the risk of ulcerative colitis (UC)-related cancer through its anti-inflammatory effect and induction of oxidative stress in cancer cells by inhibiting the glutamate-cystine transporter, which is closely associated with the cancer stem cell surface marker CD44v9. This study aimed to quantify the effects of sulfasalazine on CD44v9 expression and pathological factors in colorectal cancers (CRCs) arising from UC. Twenty-six patients with UC-related cancer were classified into groups according to the length of sulfasalazine treatment as follows: (1) long-term (LT) (≥ 5 years) and (2) short-term (ST) (< 5 years). Using immunohistochemistry, we compared CD44v9 and Ki-67 expression and pathological characteristics of each group's tumors. In vitro assay was performed to investigate the effect of sulfasalazine on epithelial differentiation and proliferation of CD44(+) cancer cells. Immunohistochemical analysis revealed that CD44v9 expression tended to be lower in the LT group (LT:ST=15.4%:46.2%, P=0.20), and Ki-67/CD44v9 double-stained cells were significantly lower in the LT group (LT:ST=0%:6.9%, P=0.01). Pathologically, the frequency of well-differentiated adenocarcinomas was higher in the LT group (LT:ST=84.6%:3...Continue Reading
References
Jan 1, 1996·Cancer·T MiwaH Nakano
Feb 17, 2001·Cancer·N YanagisawaI Okayasu
May 30, 2001·Mutation Research·A L Jackson, L A Loeb
Oct 6, 2001·Leukemia·P W GoutN Bruchovsky
Feb 16, 2002·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·T MizoshitaM Tatematsu
Dec 20, 2002·Nature·Lisa M Coussens, Zena Werb
May 12, 2004·Cancer Biology & Therapy·Rong-Jun GuoJohn P Lynch
May 26, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Helene PelicanoPeng Huang
Jul 5, 2005·Gut·T P van StaaH G M Leufkens
Sep 26, 2007·International Journal of Cancer. Journal International Du Cancer·Alessandro FedericoCarmela Loguercio
Nov 19, 2008·Oncogene·R-S ChenW Li
May 14, 2009·World Journal of Gastroenterology : WJG·Dongho ChoiSeung-Sam Paik
Sep 18, 2010·Inflammatory Bowel Diseases·Toshiaki WatanabeUNKNOWN Japanese Society for Cancer of the Colon and Rectum
Mar 15, 2011·Cancer Cell·Takatsugu IshimotoHideyuki Saya
May 2, 2012·Proceedings of the National Academy of Sciences of the United States of America·Keiichiro SakumaReiji Kannagi
Jan 16, 2013·Cancer Research·Momoko YoshikawaOsamu Nagano
Jan 22, 2013·Oncogene·O NaganoH Saya
Apr 24, 2013·Journal of Surgical Oncology·Shi ChenMu-Yan Cai
Jul 16, 2013·Cancer Science·Takeyuki WadaOsamu Nagano
Citations
Nov 23, 2017·Clinical and Experimental Pharmacology & Physiology·Berna KarakoyunGöksel Şener
Nov 8, 2018·Mediators of Inflammation·Nattawan SuwannakulMariko Murata
Dec 21, 2019·Cancer Cell International·Wei-Zhao PengJian-Zheng Jie
Apr 24, 2020·MSphere·Wenfei WangXinchun Chen
Oct 19, 2017·Cancer Research·Fumiyasu OkazakiHideto To
Dec 10, 2020·Journal of Clinical Biochemistry and Nutrition·Young-Min HanKi Baik Hahm
Mar 18, 2021·Cancer & Metabolism·Malinee ThaneeWatcharin Loilome
Feb 23, 2020·Current Drug Targets·Tomasz MackiewiczJakub Fichna
Sep 18, 2021·Molecular Carcinogenesis·Carly S WilderJohn DiGiovanni